Uray, I P <br/><br/>
Pharmacological separation of the expression of tissue transglutaminase and apoptosis after chemotherapeutic treatment of HepG2 cells.  [electronic resource] 

 -  Molecular pharmacology  Jun 2001 
 - 1388-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0026-895X 
<br/><br/><label>Standard No.: </label>10.1124/mol.59.6.1388  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Caspase 3<br/>Caspases--metabolism<br/>Cisplatin--pharmacology<br/>Fas Ligand Protein<br/>Gene Expression--drug effects<br/>Humans<br/>Interleukin-6--pharmacology<br/>Membrane Glycoproteins--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Receptors, Retinoic Acid--agonists<br/>Retinoid X Receptors<br/>Transcription Factors--agonists<br/>Transglutaminases--drug effects<br/>Tumor Cells, Cultured<br/>bcl-X Protein